Highly active antiretroviral therapy started in infants under 3 months of age: 72-week follow-up for CD4 cell count, viral load and drug resistance outcome.

Highly active antiretroviral therapy started in infants under 3 months of age: 72-week follow-up for CD4 cell count, viral load and drug resistance outcome.

OBJECTIVE: To assess the feasibility and impact of highly active antiretroviral therapy (HAART) started in vertically HIV-1-infected infants less than 3 months of age. DESIGN: A multicentre, phase I/II, non-randomized, open-label study (PENTA 7). METHODS: Adverse events, plasma HIV-1 RNA, CD4 cell...

書目詳細資料
Main Authors:	Aboulker, J, Babiker, A, Chaix, M, Compagnucci, A, Darbyshire, J, Debré, M, Faye, A, Giaquinto, C, Gibb, D, Harper, L, Saïdi, Y, Walker, A
格式:	Journal article
語言:	English
出版:	2004

相似書籍

Comparison of dual nucleoside-analogue reverse-transcriptase inhibitor regimens with and without nelfinavir in children with HIV-1 who have not previously been treated: the PENTA 5 randomised trial
由: Aboulker, J, et al.
出版: (2002)

Neurodevelopment at 11 months after starting antiretroviral therapy within 3 weeks of life
由: Barbara Laughton, et al.
出版: (2019-10-01)

A randomized controlled trial of genotypic HIV drug resistance testing in HIV-1-infected children: the PERA (PENTA 8) trial.
由: Green, H, et al.
出版: (2006)

Daily co-trimoxazole prophylaxis in severely immunosuppressed HIV-infected adults in Africa started on combination antiretroviral therapy: an observational analysis of the DART cohort.
由: Walker, A, et al.
出版: (2010)

Age and CD4 count at initiation of antiretroviral therapy in HIV-infected children: effects on long-term T-cell reconstitution.
由: Lewis, J, et al.
出版: (2012)

First-line antiretroviral therapy with a protease inhibitor versus non-nucleoside reverse transcriptase inhibitor and switch at higher versus low viral load in HIV-infected children: an open-label, randomised phase 2/3 trial.
由: Babiker, A, et al.
出版: (2011)

Recycling tenofovir in second-line antiretroviral treatment with dolutegravir: outcomes and viral load trajectories to 72 weeks
由: Keene, CM, et al.
出版: (2023)

Nevirapine/zidovudine/lamivudine has superior immunological and virological responses not reflected in clinical outcomes in a 48-week randomized comparison with abacavir/zidovudine/lamivudine in HIV-infected Ugandan adults with low CD4 cell counts.
由: Munderi, P, et al.
出版: (2010)

Evolution of antiretroviral phenotypic and genotypic drug resistance in antiretroviral-naive HIV-1-infected children treated with abacavir/lamivudine, zidovudine/lamivudine or abacavir/zidovudine, with or without nelfinavir (the PENTA 5 trial).
由: Gibb, D, et al.
出版: (2002)

When should children with HIV infection be started on antiretroviral therapy?
由: Steven B Welch, et al.
出版: (2008-03-01)

Monitoring of highly active antiretroviral therapy in HIV infection.
由: Walker, A, et al.
出版: (2011)

The impact of different CD4 cell-count monitoring and switching strategies on mortality in HIV-infected African adults on antiretroviral therapy: an application of dynamic marginal structural models
由: Ford, D, et al.
出版: (2015)

The Impact of Different CD4 Cell-Count Monitoring and Switching Strategies on Mortality in HIV-Infected African Adults on Antiretroviral Therapy: An Application of Dynamic Marginal Structural Models.
由: Ford, D, et al.
出版: (2015)

Short-term CD4 cell response after highly active antiretroviral therapy initiated at different times from seroconversion in 1,500 seroconverters.
由: Babiker, A, et al.
出版: (2003)

Immediate start of antiretroviral, why not?
由: Elaine Monteiro Matsuda, et al.

Getting started with Google Apps /
由: 192197 Darbyshire, Paul, et al.
出版: (c201)

Causes and timing of mortality and morbidity among late presenters starting antiretroviral therapy in the REALITY trial
由: Post, F, et al.
出版: (2018)

Thymic Output and CD4 T-Cell Reconstitution in HIV-Infected Children on Early and Interrupted Antiretroviral Treatment: Evidence from the Children with HIV Early Antiretroviral Therapy Trial
由: Lewis, J, et al.
出版: (2017)

Analysis of multivariate failure-time data from HIV clinical trials.
由: Walker, A, et al.
出版: (2000)

Short-term risk of AIDS according to current CD4 cell count and viral load in antiretroviral drug-naive individuals and those treated in the monotherapy era
由: Beral, V, et al.
出版: (2004)

Issues in the design and analysis of therapeutic trials in human immunodeficiency virus infection
由: Babiker, A, et al.
出版: (1998)

Markers of HIV infection in the Concorde trial. Concorde Co-ordinating Committee.
由: Walker, A, et al.
出版: (1998)

Development and validation of decision rules to guide frequency of monitoring CD4 cell count in HIV-1 infection before starting antiretroviral therapy.
由: Buclin, T, et al.
出版: (2011)

Lopinavir/ritonavir monotherapy after 24 weeks of second-line antiretroviral therapy in Africa: a randomized controlled trial (SARA).
由: Gilks, C, et al.
出版: (2012)

When to start antiretroviral therapy in infants and children
由: Mark F Cotton, et al.
出版: (2009-12-01)

Randomization-based methods for correcting for treatment changes: examples from the Concorde trial.
由: White, I, et al.
出版: (1999)

Impact of treatment changes on the interpretation of the Concorde trial.
由: White, I, et al.
出版: (1997)

Predicting patterns of long-term CD4 reconstitution in HIV-infected children starting antiretroviral therapy in sub-Saharan Africa: a cohort-based modelling study.
由: Picat, M, et al.
出版: (2013)

Cost Effectiveness Analysis of Clinically Driven versus Routine Laboratory Monitoring of Antiretroviral Therapy in Uganda and Zimbabwe
由: Lara, A, et al.
出版: (2012)

Rapid antiretroviral therapy initiation in low- and middle-income countries: A resource-based approach
由: Tenforde, M, et al.
出版: (2019)

Response to highly active antiretroviral therapy varies with age: the UK and Ireland Collaborative HIV Paediatric Study.
由: Walker, A, et al.
出版: (2004)

When to start antiretroviral therapy in HIV-associated tuberculosis.
由: Török, M, et al.
出版: (2011)

Active cytomegalovirus retinitis after the start of antiretroviral therapy
由: Heiden, D, et al.
出版: (2018)

When to start antiretroviral therapy in HIV-infected children
由: Tammy Meyers
出版: (2002-07-01)

Biphasic decay of cell-associated HIV-1 DNA in HIV-1-infected children on antiretroviral therapy.
由: De Rossi, A, et al.
出版: (2002)

Age as a determinant of survival in HIV infection.
由: Babiker, A, et al.
出版: (2001)

Start to finish : 24 weeks to an endurance triathlon /
由: 392625 Huddle, Paul, et al.
出版: (2004)

Weekly, monthly and seasonal rainfall at Bengaluru in Karnataka
由: B.T. RAVINDRABABU, et al.
出版: (2010-12-01)

Development and validation of decision rules to guide frequency of monitoring CD4 cell count in HIV-1 infection before starting antiretroviral therapy.
由: Thierry Buclin, et al.
出版: (2011-01-01)

Same Week: Feasibility of Rapid Antiretroviral Initiation in Brazil
由: Elaine Monteiro Matsuda, et al.
出版: (2021-01-01)